Original Article
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Dec 28, 2012; 18(48): 7242-7250
Published online Dec 28, 2012. doi: 10.3748/wjg.v18.i48.7242
Highlights for α-fetoprotein in determining prognosis and treatment monitoring for hepatocellular carcinoma
Xin-Sen Xu, Kai Qu, Chang Liu, Yue-Lang Zhang, Jun Liu, Yan-Zhou Song, Peng Zhang, Si-Nan Liu, Hu-Lin Chang
Xin-Sen Xu, Kai Qu, Chang Liu, Jun Liu, Yan-Zhou Song, Peng Zhang, Si-Nan Liu, Hu-Lin Chang, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Medical College, Xi’an Jiaotong University, Xi’an 710061, Shaanxi Province, China
Yue-Lang Zhang, Department of Radiology, The First Affiliated Hospital of Medical College, Xi’an Jiaotong University, Xi’an 710061, Shaanxi Province, China
Author contributions: Xu XS and Qu K contributed equally to this work; Xu XS participated in research design and in the writing of the paper; Qu K participated in the writing of the paper and in literature searches; Liu C participated in research design; Zhang YL participated in research design and revision of the paper, gave much advice about research design, assisted in division of the labor and shared many opinions on the current overview of AFP influence on diagnosis and treatment monitoring in hepatocellular carcinoma; Liu J and Song YZ participated in literature searches; Zhang P, Liu SN and Chang HL participated in data analysis.
Supported by National Natural Science Foundation of China, No. 30872482 and No. 81072051
Correspondence to: Chang Liu, MD, PhD, Professor, Department of Hepatobiliary Surgery, The First Affiliated Hospital of Medical College, Xi’an Jiaotong University, Xi’an 710061, Shaanxi Province, China. liuchangdoctor@163.com
Telephone: +86-29-85323900 Fax: +86-29-82654746
Received: July 19, 2012
Revised: August 9, 2012
Accepted: August 26, 2012
Published online: December 28, 2012
Processing time: 195 Days and 23.5 Hours
Core Tip